Patients with combined features of systemic lupus erythematosus (SLE), scleroderma, and polymyositis and high titres of antibodies to an extractable nuclear antigen (ENA), sensitive to ribonuclease (RNase), have been described as having mixed connective tissue disease (MCTD).' Immunofluorescence studies of skin biopsies from patients with some rheumatological diseases have shown the deposition of nuclear immunoglobulin G (IgG) in some cases,2-5 and several of these patients also had circulating antibodies to ENA.4 5 It is therfore possible that the epidermal nuclear IgG deposits in skin may be a feature of MCTD.
Patients with combined features of systemic lupus erythematosus (SLE), scleroderma, and polymyositis and high titres of antibodies to an extractable nuclear antigen (ENA), sensitive to ribonuclease (RNase), have been described as having mixed connective tissue disease (MCTD).' Immunofluorescence studies of skin biopsies from patients with some rheumatological diseases have shown the deposition of nuclear immunoglobulin G (IgG) in some cases,2-5 and several of these patients also had circulating antibodies to ENA.4 5 It is therfore possible that the epidermal nuclear IgG deposits in skin may be a feature of MCTD.
In the present study we have performed immunofluorescence studies of skin biopsies from patients with connective tissue diseases, including some with clinical characteristics of MCTD. 6 We investigated whether nuclear immunoglobulin deposits correlated with a clinical diagnosis and/or the presence of antibodies to ENA in serum.
Materials and methods

PATI ENTS
A group of 15 patients (14 women and one man) Accepted for publication 5 February 1982. Correspondence to P. Andersen 
'Not all areas of biopsy were stained. DIF = direct immunofluorescence.
group
obtained with skin biopsies from the 9 patients shown in Table 1 . No deposits of Ig or complement were observed in the remaining 21 patients. Nuclear IgG staining was seen in cells of the epidermis (Fig. 1) After addition of NHS to the sections as a complement source staining of C3 was observed in all specimens with IgG nuclear deposits, and the intensity of staining was generally stronger than with the antiIgG conjugate. One biopsy negative for IgG nuclear deposits showed a positive reaction with an anti-C3 conjugate after addition of NHS to the sections, though not all areas in the sections were stained. This biopsy was from a male patient thought to have polymyositis (no. 7) , and receiving steroids at the time of investigation. Granular IgG deposits at the dermoepidermal junction were found in 4 cases, 2 (nos 2 and 6) with nuclear deposits also, and 2 patients (nos 8 and 9) with SLE, who had IgG deposits at the dermoepidermal junction only. Antibodies to ENA were detected in all 7 patients with nuclear fluorescence. In one of these patients (no. 6) ENA antibodies were found only in the first serum sample investigated and were absent 7 months later, although nuclear IgG deposits could still be demonstrated in the skin. Positive tests for ENA antibody were in all cases abolished by RNase, and were not detected in serum from patients without nuclear fluorescence of epidermal cells.
In the 6 patients with nuclear IgG deposits the tentative clinical diagnosis was MCTD in 4 and SLE in 2. However, one of the cases classified as SLE (no. 6) had only 3 ARA criteria, with no LE cells and no antibodies to DNA. It appears from Table 2 that the serum IgG ANA titres were generally higher in patients with nuclear fluorescence (nos 1-7) than in patients without deposits (nos 8-15). 
